'Hazard ratio 95 ci' presentation slideshows

Seung-Jung Park, MD, PhD On behalf of the BEST investigators

Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease (BEST Trial). Seung-Jung Park, MD, PhD On behalf of the BEST investigators. Professor of Medicine, University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea. Introduction.

365 views • 36 slides

Welcome to the 6 th European Bifurcation Club 22-23 October 2010 - BUDAPEST

Welcome to the 6 th European Bifurcation Club 22-23 October 2010 - BUDAPEST. Impact of bifurcation technique on 2-year outcomes in 773 pts with distal unprotected left main coronary artery disease, impact of technique. Dr. Tullio Palmerini. Istituto di Cardiologia Policlinico S. Orsola

255 views • 24 slides

16-year follow -up of the DAN ish A cute M yocardial I nfarction 2 ( DANAMI-2 ) trial

272 views • 23 slides

COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation

COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation. Purpose To compare the efficacy of optimal medical therapy (OMT) alone versus percutaneous coronary intervention (PCI) and OMT in reducing cardiovascular risk in patients with stable coronary artery disease.

374 views • 8 slides